$0.31
-0.01 (-2.54%)
Open$0.32
Previous Close$0.32
Day High$0.32
Day Low$0.31
52W High$0.50
52W Low$0.24
Volume—
Avg Volume492.9K
Market Cap31.53M
P/E Ratio—
EPS$-0.06
SectorPharmaceuticals
Analyst Ratings
Strong Buy
6 analysts
Price Target
+4,928.9% upside
Current
$0.31
$0.31
Target
$15.64
$15.64
$13.90
$15.64 avg
$22.29
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 993.4K | 1.01M | 13.95M |
| Net Income | -4,733,943 | -4,326,308 | 2.16M |
| Profit Margin | -477.1% | -453.3% | 15.5% |
| EBITDA | -4,358,876 | -4,204,845 | 3.52M |
| Free Cash Flow | — | — | 2.06M |
| Rev Growth | -1.5% | -1.5% | +17.1% |
| Debt/Equity | 0.02 | 0.02 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |